Tags : Insulet

PharmaShots Weekly Snapshot (March 02-06, 2020)

1. Mount Sinai Signs a Multi-Year Collaboration with Harbour BioMed to Develop Novel Biotherapies for Multiple Cancer Indications and COVID-19 Published: Mar 06, 2020 | Tags: Mount Sinai, Signs, Multi-Year, Collaboration, Harbour BioMed, Develop, Novel Biotherapies, Multiple Cancer Indications, COVID-19 2. AstraZeneca Reports Results of Imfinzi and Tremelimumab in P-III DANUBE Study for Unresectable Stage IV […]Read More

Insulet to Halt Study of Omnipod Horizon Due to Software

Shots: Insulet will pause the pivotal clinical study of its wearable insulin pump Omnipod Horizon automated glucose control system due to software bug. The company anticipates the availability of updated software by the end of Apr’2020 The software glitch in the system may result in incorrect glucose value calculation which has the potential to impact […]Read More

Abbott Collaborates with Insulet to Integrate Glucose Sensing Technology with

Shots: The collaboration will combine Abbott’s CGM technology with Insulet’s Omnipod Horizon system to provide accurate, easy-to-use, integrated digital health platform to the patients living with diabetes The integrated system is designed to remain in automated insulin delivery mode and is controlled via an app on a user’s smartphone to manually take a dose of […]Read More